Overview
Iratxe Macias practices practicing medicine in Barakaldo, Spain.
Their clinical expertise encompasses Osteogenesis Imperfecta, Congenital Erythropoietic Porphyria, Osteoporosis, and Porphyria.
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Iratxe Macias
Is Iratxe Macias a top-rated expert for Osteogenesis Imperfecta?
MediFind is an objective health platform that identifies experts based on real-world data. Iratxe Macias is classified as an Experienced expert for Osteogenesis Imperfecta, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Iratxe Macias participate in research or clinical trials?
Yes. Iratxe Macias has published 12 articles and abstracts on conditions like Osteogenesis Imperfecta. You can view a list of Iratxe Macias's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Congenital Erythropoietic Porphyria
- Osteogenesis ImperfectaMacias isExperienced. Learn about Osteogenesis Imperfecta.
- OsteoporosisMacias isExperienced. Learn about Osteoporosis.
- PorphyriaMacias isExperienced. Learn about Porphyria.